Form 4: Roivant Sciences Director Meghan Fitzgerald Sells Shares to Cover Tax Obligations

Director Meghan Fitzgerald sold 894 common shares of Roivant Sciences Ltd. on September 12, 2024, to cover tax obligations related to the vesting of Restricted Stock Units (RSUs).

Summary

• On September 12, 2024, Meghan Fitzgerald, a director of Roivant Sciences Ltd., sold 894 common shares of the company.
• The sale was executed at a price of $12.12 per share.
• The transaction was a 'net settlement' by Roivant Sciences to cover tax withholding obligations related to the vesting and settlement of previously granted RSUs.
• Following the transaction, Fitzgerald directly owns 29,376 common shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, not necessarily reflecting a change in the director's confidence in the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company directors and executives. This transaction is not necessarily indicative of a negative outlook on the company's future performance.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial performance.

Key Dates